Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jan 15, 2024; 15(1): 24-33
Published online Jan 15, 2024. doi: 10.4239/wjd.v15.i1.24
Table 1 Baseline characteristics of atrial fibrillation-related hospitalizations with and without prediabetes (%)
Variable
Prediabetes
No prediabetes
P value
N475052918370
Age (yr)75 (67-82)78 (68-85)< 0.001
Male sex56.351.4< 0.001
Race/ethnicity< 0.001
White75.584
Black9.87.9
Hispanic7.34
API4.71.6
Comorbidities
Hypertension (uncomplicated)34.631.3< 0.001
Hyperlipidemia64.748.7< 0.001
Smoking10.510.20.033
Obesity29.914.6< 0.001
Drug abuse2.52.1< 0.001
Prior myocardial infarction10.89.6< 0.001
PVD20.212.7< 0.001
Hypothyroidism18.120.4< 0.001
Outcomes
Discharge disposition
Routine51.143.1< 0.001
Home health care23.621< 0.001
Total charges (USD), Median4115541276< 0.001
Table 2 Association between prediabetes and major adverse cardiac and cerebrovascular events in patients with atrial fibrillation and by subgroups (sex and race)
Outcome
Adjusted odds ratio (95%CI)
P value
MACCE1.34 (1.26-1.42)< 0.001
All-cause mortality0.62 (0.55-0.71)< 0.001
Cardiac arrest including ventricular fibrillation0.85 (0.072-0.99)0.043
Stroke1.69 (1.55-1.84)< 0.001
SubgroupAdjusted odds ratios of MACCE (95%CI)P value
Sex
    Male1.43 (1.33-1.54)< 0.001
    Female1.22 (1.11-1.33)< 0.001
Race/ethnicity
    White1.33 (1.24-1.42)< 0.001
    Black1.21 (1.03-1.44)< 0.001
    Hispanic1.43 (1.18-1.74)< 0.001
    API1.36 (1.00-1.85)0.05